Lycopene’s ability to inhibit the proliferation of mammary cancer cells, such as the MCF-7 cell line, extends to its interference with cell cycle progression and the inactivation of the signalling pathway of insulin-like growth factors I (IGF-I), a family of proteins that hold a pivotal role in regulating cellular growth, proliferation and survival [73]. This evidence concerns the gene IGF1 and breast cancer.